A phase I double-blind, placebo-controlled, dose-escalating study to evaluate the safety and tolerability of intravenous peramivir in healthy subjects

Trial Profile

A phase I double-blind, placebo-controlled, dose-escalating study to evaluate the safety and tolerability of intravenous peramivir in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Peramivir (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jun 2007 Interim results were presented at the 2007 Options for Control of Influenza conference.
    • 22 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top